NTBL

Notable Labs, Ltd. Ordinary Shares

Delisted

NTBL was delisted on the 22nd of October, 2024.

 

About: Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.

Employees: 16

Price charts implemented using Lightweight Charts™